ArriVent Biopharma
Accelerating the Global Development of Innovative Biopharmaceutical Products
79 employees · est. 2021
Vectura Group
We are a specialist inhalation CDMO helping you bring innovative inhaled medicines to market.
238 employees · est. 1997 · Chippenham, United Kingdom
Vectura Group is the older company (2021 vs 1997); Vectura Group is the larger of the two.
Side-by-Side Comparison
| Metric | ArriVent Biopharma | Vectura Group |
|---|---|---|
| Founded | ||
| Founded | 2021 | 1997 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Chippenham, United Kingdom |
| Employees | ||
| Employees | 79 | 238 larger |
| Industry | ||
| Industry | Biotechnology, Life Sciences, Pharmaceutical | Not tracked yet |
| Funding Stage | ||
| Funding Stage | IPO | Unknown |
| Total Funding | ||
| Total Funding | $564.00M | $1.26B |
| Funding Rounds | ||
| Funding Rounds | 5 | 6 |
| Services | ||
| Services | Drug Identification, Medicine Development, Commercialization of Differentiated Medicines, Strategic Collaborations, Regulatory Path Design | Inhalation Product Development, Inhalation Formulation Expertise, Bespoke Inhalation Device Design, Inhalation Clinical Trial Production and Supply, Drug and Reagent Handling, Assembly Labeling and Packaging |
| Target Customers | ||
| Target Customers | Cancer Patients, Healthcare Providers, Global Patient Communities, Biopharmaceutical Partners | Pharmaceutical Companies, MedTech Companies, Biotech Companies, Healthcare Providers, Patients |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Development, Oncology Focus, Innovative Drug Candidates, Global Market Access, Strategic Collaborations, Emerging Biotech Hubs, Unmet Medical Needs, Drug Candidate Acceleration, Cancer Therapy, Best-in-Class Therapies | Inhalation CDMO, Inhaled Drug Delivery, Pharmaceutical Development, Inhaled Medicines, Proprietary Technology, Asthma Treatment, COPD Treatment, Respiratory Therapies, Airways Diseases, Formulation Development, Drug Development, Royalty Streams, Clinical Development, Life Sciences |
| Website | ||
| Website | arrivent.com | vectura.com |
About ArriVent Biopharma
ArriVent Biopharma, founded in 2021, is at the forefront of accelerating the global development of innovative biopharmaceutical products. Operating within the Biotechnology, Life Sciences, and Pharmaceutical industries, the company leverages a deep, global network to source unique and best-in-class...
About Vectura Group
Vectura Group is a UK-based specialist in inhalation drug delivery, leveraging its extensive expertise in developing and delivering complex inhaled therapies. Founded in 1997, Vectura boasts proprietary technology and pharmaceutical development expertise, positioning itself as a unique player in the...
We will tell you when either one moves
BounceWatch watches ArriVent Biopharma and Vectura Group for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ArriVent Biopharma and Vectura Group — by email.
Frequently Asked Questions
Compare ArriVent Biopharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ArriVent Biopharma on 28 Jan 2026, and Vectura Group on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
